Cargando…

Targeting Cancer Stem Cells to Overcome Chemoresistance

Cancers are heterogeneous at the cell level, and the mechanisms leading to cancer heterogeneity could be clonal evolution or cancer stem cells. Cancer stem cells are resistant to most anti-cancer treatments and could be preferential targets to reverse this resistance, either targeting stemness pathw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nunes, Toni, Hamdan, Diaddin, Leboeuf, Christophe, El Bouchtaoui, Morad, Gapihan, Guillaume, Nguyen, Thi Thuy, Meles, Solveig, Angeli, Eurydice, Ratajczak, Philippe, Lu, He, Di Benedetto, Mélanie, Bousquet, Guilhem, Janin, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321478/ https://www.ncbi.nlm.nih.gov/pubmed/30551640 http://dx.doi.org/10.3390/ijms19124036

Ejemplares similares

Genomics applied to the treatment of breast cancer
por: Hamdan, Diaddin, et al.
Publicado: (2019)

High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target
por: Bousquet, Guilhem, et al.
Publicado: (2019)

Metastatic clear-cell renal cell carcinoma: a frequent NOTCH1 mutation predictive of response to anti-NOTCH1 CB-103 treatment
por: Bui, Thi Oanh, et al.
Publicado: (2023)

EGFR is involved in dermatofibrosarcoma protuberans progression to high grade sarcoma
por: Osio, Amélie, et al.
Publicado: (2018)

Genomics of Breast Cancer Brain Metastases: A Meta-Analysis and Therapeutic Implications
por: Nguyen, Thuy Thi, et al.
Publicado: (2023)

How to Make Anticancer Drugs Cross the Blood–Brain Barrier to Treat Brain Metastases
por: Angeli, Eurydice, et al.
Publicado: (2019)

Re‐exploring immune‐related side effects of docetaxel in an observational study: Blood hypereosinophilia
por: Hamdan, Diaddin, et al.
Publicado: (2019)

Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma
por: Bousquet, Guilhem, et al.
Publicado: (2015)

Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer
por: Bousquet, Guilhem, et al.
Publicado: (2017)

Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes
por: Nguyen, Thuy Thi, et al.
Publicado: (2020)

Expression of angiopoietin-like 4 fibrinogen-like domain (cANGPTL4) increases risk of brain metastases in women with breast cancer
por: Dao, Tu, et al.
Publicado: (2020)

A digestive allergic reaction with hypereosinophilia imputable to docetaxel in a breast cancer patient: a case report
por: Hamdan, Diaddin, et al.
Publicado: (2015)

Olaparib in the Setting of Radiotherapy-Associated Sarcoma: What Can Precision Medicine Offer For Rare Cancers?
por: Hamdan, Diaddin, et al.
Publicado: (2023)

Pulsed-laser irradiation of multifunctional gold nanoshells to overcome trastuzumab resistance in HER2-overexpressing breast cancer
por: Nunes, Toni, et al.
Publicado: (2019)

Brain Metastasis Treatment: The Place of Tyrosine Kinase Inhibitors and How to Facilitate Their Diffusion across the Blood–Brain Barrier
por: Angeli, Eurydice, et al.
Publicado: (2021)

A Boom in Nanotechnologies for a High Level of Precision Medicine
por: Angeli, Eurydice, et al.
Publicado: (2023)

The Pharmacology of Xenobiotics after Intracerebro Spinal Fluid Administration: Implications for the Treatment of Brain Tumors
por: Paris, Justine, et al.
Publicado: (2021)

Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodes
por: Furet, Elise, et al.
Publicado: (2017)

HER2 Amplification Level Predicts Pathological Complete Response in the Neoadjuvant Setting of HER2-Overexpressing Breast Cancer: A Meta-Analysis and Systematic Review
por: Gonullu, Burak, et al.
Publicado: (2023)

Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting
por: Romero, Martha, et al.
Publicado: (2016)

Cell Death Induced on Cell Cultures and Nude Mouse Skin by Non-Thermal, Nanosecond-Pulsed Generated Plasma
por: Duval, Arnaud, et al.
Publicado: (2013)

Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients
por: Verneuil, Laurence, et al.
Publicado: (2015)

Micromolecular methods for diagnosis and therapeutic strategy: a case study
por: Elbouchtaoui, Morad, et al.
Publicado: (2018)

Reactive resistance to anti-angiogenic drugs
por: Bousquet, Guilhem, et al.
Publicado: (2015)

Development, validation and clinical impact of a prediction model for 6-month mortality in older cancer patients: the GRADE
por: Angeli, Eurydice, et al.
Publicado: (2020)

A massive open online course to teach undergraduate medical students in oncology: keys of success
por: Hamdan, Diaddin, et al.
Publicado: (2022)

The Fhit protein: an opportunity to overcome chemoresistance
por: Gaudio, Eugenio, et al.
Publicado: (2016)

Cisplatin for cancer therapy and overcoming chemoresistance
por: Ranasinghe, Ranmali, et al.
Publicado: (2022)

Immunometabolism at the cornerstone of inflammaging, immunosenescence, and autoimmunity in COVID-19
por: Omarjee, Loukman, et al.
Publicado: (2020)

Disrupting the endothelin and Wnt relationship to overcome chemoresistance
por: Rosanò, Laura, et al.
Publicado: (2015)

Overcoming Chemoresistance via Extracellular Vesicle Inhibition
por: Hayatudin, Raeesah, et al.
Publicado: (2021)

Editorial: Strategies in overcoming the chemoresistance in colorectal cancer
por: Vodenkova, Sona, et al.
Publicado: (2023)

Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma
por: Ramani, Vishnu C., et al.
Publicado: (2015)

Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma
por: Salaroglio, Iris Chiara, et al.
Publicado: (2014)

Mitochondria: Insights into Crucial Features to Overcome Cancer Chemoresistance
por: Genovese, Ilaria, et al.
Publicado: (2021)

Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance
por: Bessone, Federica, et al.
Publicado: (2021)

Eggmanone Effectively Overcomes Prostate Cancer Cell Chemoresistance
por: Xie, Chen, et al.
Publicado: (2021)

Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib
por: Serova, Maria, et al.
Publicado: (2016)

MicroRNA181a Is Overexpressed in T-Cell Leukemia/Lymphoma and Related to Chemoresistance
por: Yan, Zi-Xun, et al.
Publicado: (2015)

TP53 Status and Response to Treatment in Breast Cancers
por: Varna, Mariana, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_dcb4k6ldvp43kuus4vsrun4nag